Grifols Partnership (Parenterals CDMO)
Barcelona, Spain
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (5)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
✓ HC GMP (10)
Quick Facts: Grifols Partnership (Parenterals CDMO)
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Barcelona, Spain
- Website
- https://www.partnership.grifols.com/
- Modalities
- Sterile Injectables, IV Bags, Sterile Fill-Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Grifols Partnership (Parenterals CDMO)
Grifols Partnership (Parenterals CDMO) makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Sterile Injectables, IV Bags, Sterile Fill-Finish. 2 manufacturing sites registered with the U.S. FDA. Website: https://www.partnership.grifols.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Grifols Partnership (Parenterals CDMO) FDA Inspection History
2026-06
2025-09
2024-07
2023-10
2022-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-06-19 |
Laboratorios Grifols, S.A.
Parets Del Valles
Company-level
|
Blood and Blood Products | No | No Action Indicated (NAI) |
| 2025-09-10 |
Laboratorios Grifols S.A.
Las Torres De Cotillas
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2024-07-26 |
Laboratorios Grifols, S.A.
Parets Del Valles
Company-level
|
Blood and Blood Products | Yes | Voluntary Action Indicated (VAI) |
| 2023-10-27 |
Laboratorios Grifols, S.A.
Parets Del Valles
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2022-11-10 |
Laboratorios Grifols S.A.
Las Torres De Cotillas
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Grifols Partnership (Parenterals CDMO) FDA 483 Findings 4 observations · 2024-07-26 → 2024-07-26 ?
By subsystem
By severity
- 3 — Moderate: 1
- 2 — Minor: 3
- Repeat observations: 0
Most severe findings
-
Complete Test Data
"Laboratory records are deficient in that they do not include a complete record of all data obtained during testing."
-
Written procedures fail to include
"Written procedures for cleaning and maintenance fail to include description in sufficient detail of methods, equipment and materials used."
-
Batch production and Batch Control Record Requirements
"The batch production and control records are deficient in that they do not include documentation of the accomplishment of each significant step in manufacturing."
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Grifols Partnership (Parenterals CDMO)
How many FDA inspections does Grifols Partnership (Parenterals CDMO) have on record?
CDMO Signal tracks 5 FDA inspections for Grifols Partnership (Parenterals CDMO), sourced from the FDA inspection database. See the full inspection history above.
Has Grifols Partnership (Parenterals CDMO) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Grifols Partnership (Parenterals CDMO).
Does Grifols Partnership (Parenterals CDMO) have a CDMO Signal Score?
Not yet. Grifols Partnership (Parenterals CDMO) is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Grifols Partnership (Parenterals CDMO) for a manufacturing program?
Use the free AI matchmaker to compare Grifols Partnership (Parenterals CDMO) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Gland Pharma
Hyderabad, India · Visakhapatnam, India · France · Belgium
Sterile Fill-Finish, Sterile Injectables, Small Molecule API
Exela Pharma Sciences
Lenoir, North Carolina, United States
Sterile Injectables, Lyophilization, IV Bags, Prefilled Syringes
Aspen CDMO
Notre-Dame-de-Bondeville, France
Sterile Injectables, Prefilled Syringes, IV Bags, Heparin API, Small Molecule API, High-Potency APIs, Peptides
Solupharm
Melsungen, Germany
Sterile Injectables, Sterile Fill-Finish
Nipro Pharma
Osaka, Japan
Sterile Injectables, Prefilled Syringes, Oral Solid Dose, Topicals, Sterile Fill-Finish
Compare Grifols Partnership (Parenterals CDMO) with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.